Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-021115
Filing Date
2024-08-12
Accepted
2024-08-12 20:30:55
Documents
1
Period of Report
2024-08-08

Document Format Files

Seq Description Document Type Size
1 form4-08132024_120852.html 4  
1 form4-08132024_120852.xml 4 3948
  Complete submission text file 0001415889-24-021115.txt   5429
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address
Strohl William (Reporting) CIK: 0001786198 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39045 | Film No.: 241198423